阿兹武丁通过准急性髓性白血病的TERT/p21轴,表现出强大的诱导差异化的作用
Chan-Seong Kwon1, Ji-Eun Lee1, Byeol-Eun Jeon1
1Department of Integrated Biological Science, Pusan National University, Busan 46241, South Korea.
概括
抗艾滋病毒药物阿兹武丁通过准端粒酶逆转录酶 (TERT) 有效地诱导急性髓性白血病 (AML) 细胞的分化. 这种新的方法显示出AML治疗的前景,包括TP53突变患者.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 急性髓性白血病 (AML) 是一种严重的血液癌症,治疗选择有限.
- 诱导AML细胞分化是一种潜在的治疗策略,以控制增殖.
- 识别新型诱导分化剂对于推进AML治疗至关重要.
研究的目的:
- 确定能够诱导急性髓性白血病 (AML) 细胞分化的新型候选药物.
- 为了研究阿兹武丁的抗白血病作用和机制,一个重新设计的抗艾滋病毒药物,在AML.
主要方法:
- 化学图书馆的表型选,以确定诱导差异化的剂.
- 使用人类AML细胞系进行体外研究,以评估Azvudine对分化,细胞周期和亡的影响.
- 使用小鼠异种移植模型的体内研究来评估Azvudine在减少瘤负担和延长生存时间方面的有效性.
- 机理学研究以阐明Azvudine的分子点和途径,包括端粒酶活性,DNA损伤反应和反应性氧物种 (ROS) 生产.
主要成果:
- 阿兹武丁被确定为多个AML细胞系中强有力的分化诱导剂,与G2/M细胞周期停止和细胞亡有关.
- 在体内研究表明,阿兹夫丁能够刺激AML细胞分化,减少瘤负担和转移,并改善小鼠的生存率.
- 在患者获得的AML样本中观察到阿兹布丁的抗白血病作用,包括那些具有不良TP53突变的样本.
- 机理学调查显示,阿兹韦丁抑制了端粒酶逆转录酶 (TERT),导致端粒功能障碍,DNA损伤,p21上调和随后的分化. 它还增加了线粒体ROS,调节Bcl-2蛋白质并促进了细胞亡.
结论:
- 阿兹布丁显示出显著的临床前疗效作为AML的差异化诱导疗法.
- 药物的机制包括TERT抑制,端粒缩短,DNA损伤反应和ROS介导的亡.
- 这些发现支持阿兹武丁用于AML治疗的重新定位,特别是考虑到对端粒酶向疗法的临床兴趣.
相关概念视频
01:15Differentiation of Common Myeloid Progenitor Cells
3.3K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.3K
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
01:10Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
00:57Cellular Differentiation
3.7K
How does a complex organism such as a human develop from a single cell? It all starts from a single fertilized egg which gives rise to a vast array of cell types, such as nerve cells, muscle cells, and epithelial cells that characterize the adult? Throughout development and adulthood, cellular differentiation leads cells to assume their final morphology and physiology. Differentiation is the process by which unspecialized cells become specialized to carry out distinct functions.
A zygote is a...
A zygote is a...
3.7K
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
01:21Lineage Commitment
3.2K
Commitment is the process whereby stem cells:
3.2K